THORATEC CORPORATION | 24,181 Euro | +0,729 +3,11 % | |
| WKN: 867805 ISIN: US8851753074 Ticker-Symbol: TL1 | Frankfurt | 24.05.13 | 09:01 Uhr |
Branche GesundheitswesenAktienmarkt S&P MidCap 400 |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 23.05. | Thoratec, A Bio Stock With Good Potential And Products | - | Seeking Alpha | |
| 20.05. | FDA Nod for Thoratec Controller | - | Zacks | |
| 20.05. | Goldman Sachs stuft Thoratec von Buy auf Neutral ab | 76 | BörseGo | |
| Goldman Sachs stuft Thoratec von Buy auf Neutral ab
(© BörseGo AG 2013 - Autor: Thomas Gansneder, Redakteur) Mehr lesen zu: Goldman Sachs stuft Thoratec von Buy auf Neutral ab | ||||
| 17.05. | Thoratec Wins FDA Approval of HeartMate II Pocket Calculator | - | Benzinga.com | |
| 17.05. | Thoratec Announces FDA Approval Of HeartMate II Pocket Controller' | 23 | PR Newswire | |
| PLEASANTON, Calif., May 17, 2013 /PRNewswire/ --Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore... Mehr lesen zu: Thoratec Announces FDA Approval Of HeartMate II Pocket Controller' | ||||
| 14.05. | Thoratec Presentation At Bank of America Merrill Lynch 2013 Health Care Conference To Be Webcast | 13 | PR Newswire | |
| PLEASANTON, Calif., May 14, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts... Mehr lesen zu: Thoratec Presentation At Bank of America Merrill Lynch 2013 Health Care Conference To Be Webcast | ||||
| 06.05. | A Look Into Thoratec's Recent Results | - | Seeking Alpha | |
| 06.05. | Upgrade Alert for Thoratec | - | SmarTrend | |
| 06.05. | Thoratec Misses Earnings and Rev Est | - | Zacks | |
| 03.05. | THORATEC CORP - 10-Q, Quaterly Report | - | SEC Filings | |
| 03.05. | Why Thoratec Shares Tanked | - | Motley Fool | |
| 03.05. | Mid-Day Market Update: Thoratec Dips On Downbeat Profit, InvenSense Rises | 3 | Benzinga.com | |
| 03.05. | Thoratec Falling Today on Above-Average Volume | - | SmarTrend | |
| 03.05. | Stock Investors Sell Off Shares of Thoratec, Down 7.8% | 1 | SmarTrend | |
| 03.05. | Thoratec Management Discusses Q1 2013 Results - Earnings Call Transcript | 1 | Seeking Alpha | |
| 02.05. | Thoratec Reports First Quarter 2013 Results | 37 | PR Newswire | |
| PLEASANTON, Calif., May 2, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts... Mehr lesen zu: Thoratec Reports First Quarter 2013 Results | ||||
| 24.04. | Thoratec Crosses Below its 10-day MA | - | SmarTrend | |
| 22.04. | Thoratec Schedules First Quarter Conference Call, Webcast | 33 | PR Newswire | |
| PLEASANTON, Calif., April 22, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing... Mehr lesen zu: Thoratec Schedules First Quarter Conference Call, Webcast | ||||
| 19.04. | Possible Bullish Inside Day Candle Pattern Detected for Thoratec | - | SmarTrend | |
| 12.04. | Thoratec Upgraded to Neutral | - | Zacks | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| CERNER | 74,56 | +1,18 % | Cerner Corporation - Shareholder/Analyst Call |
| FRESENIUS MEDICAL CARE | 53,09 | -0,95 % | Fresenius Medical Care: Aktienrückkauf beginnt heute |
| MEDTRONIC | 39,112 | -1,62 % | Medtronic übertrifft Umsatz- und Gewinnprognosen |
| CYTORI THERAPEUTICS | 1,952 | +3,06 % | Intravase Approval Opens Vascular Market for Cytori |
| EUROFINS SCIENTIFIC | 147,95 | -1,37 % | Eurofins Scientific: Notice of Call Option Exercise |
